King Luther Capital Management Corp Abbott Laboratories Transaction History

King Luther Capital Management Corp

$21.9 Billion
Q1 2024

A detailed history of King Luther Capital Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, King Luther Capital Management Corp holds 1,615,071 shares of ABT stock, worth $167 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares

1,615,071

Previous 1,976,986 18.31%

Holding current value

$167 Million

Previous $218 Million 15.64%

% of portfolio

0.84%

Previous 1.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $39.6 Million - $43.8 Million	-361,915 Reduced 18.31%	1,615,071 $184 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $7.4 Million - $9.06 Million	-82,091 Reduced 3.99%	1,976,986 $218 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $534,585 - $641,413	-5,596 Reduced 0.27%	2,059,077 $199 Million
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $3.75 Million - $4.17 Million	37,174 Added 1.83%	2,064,673 $225 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $2.94 Million - $3.46 Million	-30,360 Reduced 1.48%	2,027,499 $205 Million

Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $1.53 Million - $1.79 Million	-16,066 Reduced 0.77%	2,057,859 $226 Million
Q3 2022 Nov 10, 2022	SELL	$96.76 - $112.03 $690,576 - $799,558	-7,137 Reduced 0.34%	2,073,925 $201 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $2.99 Million - $3.62 Million	-29,315 Reduced 1.39%	2,081,062 $226 Million
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $1.65 Million - $2.01 Million	-14,433 Reduced 0.68%	2,110,377 $250 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $3.9 Million - $4.77 Million	-33,741 Reduced 1.56%	2,124,810 $299 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $1.57 Million - $1.74 Million	13,468 Added 0.63%	2,158,551 $255 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $5.34 Million - $6.29 Million	-50,506 Reduced 2.3%	2,145,083 $249 Million
Q1 2021 May 12, 2021	SELL	$108.84 - $128.23 $3.04 Million - $3.58 Million	-27,909 Reduced 1.26%	2,195,589 $263 Million
Q4 2020 Feb 10, 2021	BUY	$105.0 - $114.42 $579,285 - $631,255	5,517 Added 0.25%	2,223,498 $243 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $1.13 Million - $1.37 Million	-12,314 Reduced 0.55%	2,217,981 $241 Million
Q2 2020 Aug 12, 2020	SELL	$76.57 - $98.0 $2.41 Million - $3.09 Million	-31,524 Reduced 1.39%	2,230,295 $204 Million
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $1.08 Million - $1.58 Million	17,226 Added 0.77%	2,261,819 $178 Million
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $2.49 Million - $2.78 Million	31,771 Added 1.44%	2,244,593 $195 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $2.14 Million - $2.33 Million	26,206 Added 1.2%	2,212,822 $185 Million
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $1.78 Million - $2.08 Million	24,454 Added 1.13%	2,186,616 $184 Million
Q1 2019 May 10, 2019	BUY	$66.22 - $80.06 $1.27 Million - $1.53 Million	19,107 Added 0.89%	2,162,162 $173 Million
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $4.96 Million - $5.62 Million	75,631 Added 3.66%	2,143,055 $155 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $700,470 - $845,033	11,519 Added 0.56%	2,067,424 $152 Million
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $3 Million - $3.31 Million	-52,170 Reduced 2.47%	2,055,905 $125 Million
Q1 2018 May 08, 2018	BUY	$56.27 - $63.62 $123,794 - $139,964	2,200 Added 0.1%	2,108,075 $126 Million
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $11.2 Million - $12 Million	209,529 Added 11.05%	2,105,875 $120 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $91.1 Million - $102 Million	1,896,346	1,896,346 $101 Million

Others Institutions Holding ABT

# of Institutions

3,129

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $181B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.

Account

King Luther Capital Management Corp Abbott Laboratories Transaction History